CoChat
Sign Up
Cited by 103

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes

Dijk, Wieneke, Beigneux, Anne P., Larsson, Mikael, Bensadoun, André, Young, Stephen G., Kersten, Sander·2016·Journal of Lipid Research
DOI 10.1194/jlr.m067363
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1194/jlr.m067363

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 59

  1. Kersten, 2014, Physiological regulation of lipoprotein lipase, Biochim. Biophys. Acta., 1841, 919, 10.1016/j.bbalip.2014.03.013 · DOI
  2. Goldberg, 2009, Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways, J. Lipid Res., 50, S86, 10.1194/jlr.R800085-JLR200 · DOI · Paper page
  3. Young, 2013, Biochemistry and pathophysiology of intravascular and intracellular lipolysis, Genes Dev., 27, 459, 10.1101/gad.209296.112 · DOI
  4. Davies, 2010, GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries, Cell Metab., 12, 42, 10.1016/j.cmet.2010.04.016 · DOI · Paper page
  5. Ben-Zeev, 1992, Maturation of lipoprotein lipase. Expression of full catalytic activity requires glucose trimming but not translocation to the cis-Golgi compartment, J. Biol. Chem., 267, 6219, 10.1016/S0021-9258(18)42684-1 · DOI
  6. Simsolo, 1992, Characterization of lipoprotein lipase activity, secretion, and degradation at different sites of post-translational processing in primary cultures of rat adipocytes, J. Lipid Res., 33, 1777, 10.1016/S0022-2275(20)41335-5 · DOI
  7. Semenkovich, 1990, In vitro expression and site-specific mutagenesis of the cloned human lipoprotein lipase gene. Potential N-linked glycosylation site asparagine 43 is important for both enzyme activity and secretion, J. Biol. Chem., 265, 5429, 10.1016/S0021-9258(19)39378-0 · DOI
  8. Ben-Zeev, 1994, Lipoprotein lipase and hepatic lipase: the role of asparagine-linked glycosylation in the expression of a functional enzyme, J. Lipid Res., 35, 1511, 10.1016/S0022-2275(20)41149-6 · DOI
  9. Davis, 1990, Combined lipase deficiency in the mouse: evidence of impaired lipase processing and secretion, J. Biol. Chem., 265, 17960, 10.1016/S0021-9258(18)38257-7 · DOI
  10. Catoire, 2014, Fatty acid-inducible ANGPTL4 governs lipid metabolic response to exercise, Proc. Natl. Acad. Sci. USA., 111, E1043, 10.1073/pnas.1400889111 · DOI · Paper page
  11. Kroupa, 2012, Linking nutritional regulation of Angptl4, Gpihbp1, and Lmf1 to lipoprotein lipase activity in rodent adipose tissue, BMC Physiol., 12, 13, 10.1186/1472-6793-12-13 · DOI · Paper page
  12. Dijk, 2015, ANGPTL4 mediates shuttling of lipid fuel to brown adipose tissue during sustained cold exposure, eLife. 10.7554/eLife.08428., 10.7554/eLife.08428.017 · DOI
  13. Kersten, 2000, Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene, J. Biol. Chem., 275, 28488, 10.1074/jbc.M004029200 · DOI · Paper page
  14. Georgiadi, 2010, Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress, Circ. Res., 106, 1712, 10.1161/CIRCRESAHA.110.217380 · DOI · Paper page
  15. Dijk, 2014, Regulation of lipoprotein lipase by Angptl4, Trends Endocrinol. Metab., 25, 146, 10.1016/j.tem.2013.12.005 · DOI
  16. Romeo, 2007, Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL, Nat. Genet., 39, 513, 10.1038/ng1984 · DOI · Paper page
  17. Robciuc, 2011, Serum angiopoietin-like 4 protein levels and expression in adipose tissue are inversely correlated with obesity in monozygotic twins, J. Lipid Res., 52, 1575, 10.1194/jlr.P015867 · DOI
  18. Smart-Halajko, 2010, The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk, Arterioscler. Thromb. Vasc. Biol., 30, 2277, 10.1161/ATVBAHA.110.212209 · DOI
  19. Robciuc, 2010, Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample, J. Lipid Res., 51, 824, 10.1194/jlr.M002618 · DOI
  20. Mehta, 2014, Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits, Arterioscler. Thromb. Vasc. Biol., 34, 1057, 10.1161/ATVBAHA.113.302802 · DOI
  21. Robciuc, 2012, Angiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubes, PLoS One., 7, e46212, 10.1371/journal.pone.0046212 · DOI
  22. Davies, 2012, Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells, J. Lipid Res., 53, 2690, 10.1194/jlr.M031559 · DOI
  23. Chi, 2015, Angiopoietin-like 4 modifies the interactions between lipoprotein lipase and its endothelial cell transporter GPIHBP1, J. Biol. Chem., 290, 11865, 10.1074/jbc.M114.623769 · DOI · Paper page
  24. Nilsson, 2012, Triacylglycerol-rich lipoproteins protect lipoprotein lipase from inactivation by ANGPTL3 and ANGPTL4, Biochim. Biophys. Acta., 1821, 1370, 10.1016/j.bbalip.2012.06.003 · DOI · Paper page
  25. Makoveichuk, 2013, Inactivation of lipoprotein lipase in 3T3-L1 adipocytes by angiopoietin-like protein 4 requires that both proteins have reached the cell surface, Biochem. Biophys. Res. Commun., 441, 941, 10.1016/j.bbrc.2013.11.013 · DOI · Paper page
  26. Voss, 2011, Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1, Proc. Natl. Acad. Sci. USA., 108, 7980, 10.1073/pnas.1100992108 · DOI
  27. Beigneux, 2011, Assessing the role of the glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) three-finger domain in binding lipoprotein lipase, J. Biol. Chem., 286, 19735, 10.1074/jbc.M111.242024 · DOI
  28. Alex, 2013, Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γ, Mol. Cell. Biol., 33, 1303, 10.1128/MCB.00858-12 · DOI
  29. Lichtenstein, 2010, Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages, Cell Metab., 12, 580, 10.1016/j.cmet.2010.11.002 · DOI · Paper page
  30. Mandard, 2006, The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity, J. Biol. Chem., 281, 934, 10.1074/jbc.M506519200 · DOI · Paper page
  31. Bengtsson-Olivecrona, 1992, Assay of lipoprotein lipase and hepatic lipase, In Lipoprotein Analysis: A Practical Approach. R. E. Skinner and C. A. Converse, editors. Oxford University Press, Oxford, UK., 169, 10.1093/oso/9780199631926.003.0007 · DOI
  32. Weinstein, 2008, Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice, J. Biol. Chem., 283, 34511, 10.1074/jbc.M806067200 · DOI · Paper page
  33. Bensadoun, 2014, A new monoclonal antibody, 4-1a, that binds to the amino terminus of human lipoprotein lipase, Biochim. Biophys. Acta., 1841, 970, 10.1016/j.bbalip.2014.03.008 · DOI
  34. Ge, 2004, Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4, J. Biol. Chem., 279, 2038, 10.1074/jbc.M307583200 · DOI · Paper page
  35. Braun, 1992, Regulation of the synthesis, processing and translocation of lipoprotein lipase, Biochem. J., 287, 337, 10.1042/bj2870337 · DOI
  36. Vannier, 1989, Biosynthesis of lipoprotein lipase in cultured mouse adipocytes. II. Processing, subunit assembly, and intracellular transport, J. Biol. Chem., 264, 13206, 10.1016/S0021-9258(18)51616-1 · DOI
  37. Cupp, 1987, Heparin decreases the degradation rate of lipoprotein lipase in adipocytes, J. Biol. Chem., 262, 6383, 10.1016/S0021-9258(18)45581-0 · DOI
  38. Sha, 2014, The ER-associated degradation adaptor protein Sel1L regulates LPL secretion and lipid metabolism, Cell Metab., 20, 458, 10.1016/j.cmet.2014.06.015 · DOI
  39. Park, 1996, Brefeldin A enables synthesis of active lipoprotein lipase in cld/cld and castanospermine-treated mouse brown adipocytes via translocation of Golgi components to endoplasmic reticulum, Biochem. J., 317, 125, 10.1042/bj3170125 · DOI
  40. Ben-Zeev, 2002, Maturation of lipoprotein lipase in the endoplasmic reticulum. Concurrent formation of functional dimers and inactive aggregates, J. Biol. Chem., 277, 10727, 10.1074/jbc.M108128200 · DOI
  41. Wang, 2009, Lipoprotein lipase: from gene to obesity, Am. J. Physiol. Endocrinol. Metab., 297, E271, 10.1152/ajpendo.90920.2008 · DOI · Paper page
  42. Brands, 2013, Omega-3 long-chain fatty acids strongly induce angiopoietin-like 4 in humans, J. Lipid Res., 54, 615, 10.1194/jlr.M030049 · DOI
  43. van Raalte, 2012, Angiopoietin-like protein 4 is differentially regulated by glucocorticoids and insulin in vitro and in vivo in healthy humans, Exp. Clin. Endocrinol. Diabetes., 120, 598, 10.1055/s-0032-1321864 · DOI
  44. Jonker, 2013, Dietary modulation of plasma angiopoietin-like protein 4 concentrations in healthy volunteers and in patients with type 2 diabetes, Am. J. Clin. Nutr., 97, 255, 10.3945/ajcn.112.043687 · DOI
  45. Makoveichuk, 2012, Inactivation of lipoprotein lipase occurs on the surface of THP-1 macrophages where oligomers of angiopoietin-like protein 4 are formed, Biochem. Biophys. Res. Commun., 425, 138, 10.1016/j.bbrc.2012.07.048 · DOI
  46. Yoshida, 2002, Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase, J. Lipid Res., 43, 1770, 10.1194/jlr.C200010-JLR200 · DOI · Paper page
  47. Desai, 2007, Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice, Proc. Natl. Acad. Sci. USA., 104, 11766, 10.1073/pnas.0705041104 · DOI · Paper page
  48. Esko, 1985, Animal cell mutants defective in glycosaminoglycan biosynthesis, Proc. Natl. Acad. Sci. USA., 82, 3197, 10.1073/pnas.82.10.3197 · DOI · Paper page
  49. Klinger, 2011, SorLA regulates the activity of lipoprotein lipase by intracellular trafficking, J. Cell Sci., 124, 1095, 10.1242/jcs.072538 · DOI
  50. Chappell, 1992, The low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor binds and mediates catabolism of bovine milk lipoprotein lipase, J. Biol. Chem., 267, 25764, 10.1016/S0021-9258(18)35675-8 · DOI · Paper page
  51. Obunike, 1996, Lipoprotein lipase degradation by adipocytes: receptor-associated protein (RAP)-sensitive and proteoglycan-mediated pathways, J. Lipid Res., 37, 2439, 10.1016/S0022-2275(20)37492-7 · DOI
  52. Cisar, 1989, Secretion and degradation of lipoprotein lipase in cultured adipocytes. Binding of lipoprotein lipase to membrane heparan sulfate proteoglycans is necessary for degradation, J. Biol. Chem., 264, 1767, 10.1016/S0021-9258(18)94253-5 · DOI
  53. Sukonina, 2006, Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue, Proc. Natl. Acad. Sci. USA., 103, 17450, 10.1073/pnas.0604026103 · DOI · Paper page
  54. Maxwell, 2005, Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment, Proc. Natl. Acad. Sci. USA., 102, 2069, 10.1073/pnas.0409736102 · DOI · Paper page
  55. Poirier, 2013, The biology of PCSK9 from the endoplasmic reticulum to lysosomes: New and emerging therapeutics to control low-density lipoprotein cholesterol, Drug Des. Devel. Ther., 7, 1135
  56. Poirier, 2009, Dissection of the endogenous cellular pathways of PCSK9-induced low density Lipoprotein receptor degradation. Evidence for an intracellular route, J. Biol. Chem., 284, 28856, 10.1074/jbc.M109.037085 · DOI · Paper page
  57. Fisher, 2001, The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways, J. Biol. Chem., 276, 27855, 10.1074/jbc.M008885200 · DOI
  58. Dijk, 2016, Regulation of lipid metabolism by angiopoietin-like proteins, Curr. Opin. Lipidol., 27, 10.1097/MOL.0000000000000290 · DOI
  59. Robciuc, 2013, Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids, Arterioscler. Thromb. Vasc. Biol., 33, 1706, 10.1161/ATVBAHA.113.301397 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Dijk, W., Beigneux, A. P., Larsson, M., Bensadoun, A., Young, S. G., & Kersten, S.
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2016-09
Volume
57
Issue
9
Pages
1670-1683
ISSN
0022-2275
DOI
10.1194/jlr.m067363
Cited by
103
References
8
Language
en
Update notices
erratum (2016-10-01)
Licence
Funders
  • Fondation Leducq (12CVD04)
  • Office of Extramural Research, National Institutes of Health (HL090533, HL087228)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review